Serum prolactin level in patients with relapsing-remitting multiple sclerosis during relapse

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
Sasan MoshirzadehHossien Pakdaman

Abstract

It has been hypothesized that hyperprolactinemia may contribute to the pathogenesis of multiple sclerosis (MS). In a case-control study, 58 patients with definite relapsing-remitting MS (RRMS) during relapse and 58 sex-matched and age-matched healthy controls were assessed for serum prolactin (PRL) concentration. Mean serum PRL levels (± standard deviation) were significantly higher in patients with MS (501.3 ± 232.6 mIU/L) than in healthy control patients (233.3 ± 142.7 mIU/L; p < 0.0001). Furthermore, these differences were consistent in each sex: females with MS (704.4 ± 119.6 mIU/L) compared to female controls (305.5 ± 156.9 mIU/L p < 0.001); and in males with MS (358.0 ± 180.0 mIU/L) compared to male controls (182.3 ± 107.5 mIU/L; p < 0.001). Our findings provided more evidence to support the hypothesis that patients with RRMS, regardless of gender, are in a hyperprolactinemic state.

References

Mar 1, 1991·Journal of the Neurological Sciences·J KiraI Goto
Feb 1, 1996·Endocrine Reviews·H O Besedovsky, A del Rey
Jun 1, 1997·Brain : a Journal of Neurology·T Wei, S L Lightman
Jun 16, 2001·International Immunopharmacology·R W McMurray
Apr 2, 2003·Endocrine·Zeynep DogusanElisabeth Hooghe-Peters

❮ Previous
Next ❯

Citations

Dec 6, 2016·International Journal of Molecular Sciences·Massimo Costanza, Rosetta Pedotti
Aug 31, 2012·Multiple Sclerosis : Clinical and Laboratory Research·Simon ZhornitskyLuanne M Metz
Sep 18, 2018·Immunology·María C Ysrraelit, Jorge Correale
Sep 2, 2019·Neuromolecular Medicine·Wildéa Lice de Carvalho Jennings PereiraEdna Maria Vissoci Reiche
Jul 29, 2020·Frontiers in Neurology·Francesca GilliAndrew R Pachner
Nov 16, 2020·Frontiers in Neuroendocrinology·Maddalena Sparaco, Simona Bonavita

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.